by Walter Gunzburg | Apr 22, 2021 | Press Release
Singapore based Company envisages going public via SPAC merger or traditional IPO SINGAPORE, April 22, 2021 Austrianova (the SG Austria group, Austrianova Singapore and Austrianova Thailand) is pleased to announce that it has signed an Agreement with GEM Global...
by Walter Gunzburg | Nov 30, 2020 | Press Release
Austrianova announced today that a key publication on the ability of its patented technology, Bac-in-a-Box, to completely protect probiotics from acidic conditions found in the stomach has been published in the well respected journal “Microbial Cell Factories”...
by Walter Gunzburg | Jul 28, 2020 | Press Release
S.E. Asian company, Austrianova, headquartered in Singapore, announced today that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA). This DMF provides all confidential and detailed information covering the production of...
by Waqas Tariq | Jun 24, 2020 | Press Release
Austrianova announced today that they are the recipients of the Emerging Enterprises 2014 Best Innovation award. The award was presented at a gala dinner and awards ceremony held at the Ritz Carlton hotel in Singapore and was organised and hosted by the main sponsor,...
by Waqas Tariq | Jun 24, 2020 | Press Release
Austrianova announced the opening of their new company facilities at Synapse, within Biopolis, a world-class biomedical sciences hub where key research institutes and organisations are located. The Company occupies lab and office space within one self contained unit...
by Waqas Tariq | Jun 24, 2020 | Press Release
Austrianova and Cells for Cells have just jointly published a ground breaking, peer reviewed, scientific publication on a novel, cost and time-saving method to generate extra-cellular vesicles (EVs) from encapsulated Mesenchymal Stem Cells (MSCs). These EVs are known...
